260 related articles for article (PubMed ID: 8793603)
1. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
[TBL] [Abstract][Full Text] [Related]
2. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):369-75. PubMed ID: 1834592
[TBL] [Abstract][Full Text] [Related]
3. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
[TBL] [Abstract][Full Text] [Related]
4. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
[TBL] [Abstract][Full Text] [Related]
5. Pantoprazole does not interact with the pharmacokinetics of carbamazepine.
Huber R; Bliesath H; Hartmann M; Steinijans VW; Koch H; Mascher H; Wurst W
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):521-4. PubMed ID: 9799054
[TBL] [Abstract][Full Text] [Related]
6. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):481-5. PubMed ID: 8520804
[TBL] [Abstract][Full Text] [Related]
7. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S58-66. PubMed ID: 8793604
[TBL] [Abstract][Full Text] [Related]
9. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration.
Bliesath H; Huber R; Hartmann M; Lühmann R; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S18-24. PubMed ID: 8793600
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole lacks induction of CYP1A2 activity in man.
Hartmann M; Zech K; Bliesath H; Steinijans VW; Koch H; Wurst W; Mascher H
Int J Clin Pharmacol Ther; 1999 Apr; 37(4):159-64. PubMed ID: 10235417
[TBL] [Abstract][Full Text] [Related]
11. No influence of pantoprazole on the pharmacokinetics of phenytoin.
Middle MV; Müller FO; Schall R; Groenewoud G; Hundt HK; Huber R; Bliesath H; Steinijans VW
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S72-5. PubMed ID: 8793606
[TBL] [Abstract][Full Text] [Related]
12. Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers.
Koch HJ; Hartmann M; Bliesath H; Huber R; Steinijans VW; Mascher H; Wurst W
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):420-3. PubMed ID: 8897078
[TBL] [Abstract][Full Text] [Related]
13. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):51-5. PubMed ID: 8929746
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
[TBL] [Abstract][Full Text] [Related]
15. Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
Simon B; Müller P; Hartmann M; Bliesath H; Lühmann R; Huber R; Bohnenkamp W; Wurst W
Z Gastroenterol; 1990 Sep; 28(9):443-7. PubMed ID: 2177296
[TBL] [Abstract][Full Text] [Related]
16. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration.
Bliesath H; Huber R; Hartmann M; Lühmann R; Wurst W
Int J Clin Pharmacol Ther; 1994 Jan; 32(1):44-50. PubMed ID: 8199751
[TBL] [Abstract][Full Text] [Related]
17. Lack of pantoprazole drug interactions in man.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):385-99. PubMed ID: 7981922
[TBL] [Abstract][Full Text] [Related]
18. Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline.
Pan WJ; Goldwater DR; Zhang Y; Pilmer BL; Hunt RH
Aliment Pharmacol Ther; 2000 Mar; 14(3):345-52. PubMed ID: 10735929
[TBL] [Abstract][Full Text] [Related]
19. Lack of pharmacokinetic interaction of pantoprazole with diazepam in man.
Gugler R; Hartmann M; Rudi J; Brod I; Huber R; Steinijans VW; Bliesath H; Wurst W; Klotz U
Br J Clin Pharmacol; 1996 Aug; 42(2):249-52. PubMed ID: 8864328
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):152-6. PubMed ID: 8861733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
